Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 730-744
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.730
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.730
Table 1 The effects of diet-derived gut bacterial metabolites on the pathogenesis of insulin resistance in various organs
| Category | Metabolite | Target organ | Effects | Ref. |
| Carbohydrate | ||||
| Fiber-derived | Acetate | Skeletal muscle | Increased lipid oxidation in vivo | Yamashita et al[75] |
| Liver | Decreased lipogenesis in vivo | den Besten et al[47] and Yamashita et al[51] | ||
| Increased lipid oxidation in vivo | den Besten et al[47], Yamashita et al[51], Kondo et al[52] and Sahuri-Arisoylu et al[53] | |||
| Adipose tissue | Stimulated adipogenesis in vitro | Ge et al[60] | ||
| Inhibited lipolysis in vitro and in vivo | Hong et al[59], Ge et al[60] and Jocken et al[61] | |||
| Increased browning in vitro and in vivo | Sahuri-Arisoylu et al[53] and Hanatani et al[73] | |||
| Whole body | Increased energy expenditure and fat oxidation in vivo and in humans | den Besten et al[47], Canfora et al[77] and van der Beek et al[78] | ||
| Propionate | Liver | Suppressed gluconeogenesis in vitro | Yoshida et al[29] | |
| Decreased lipogenesis in vivo | den Besten et al[47] | |||
| Increased lipid oxidation in vivo | den Besten et al[47] | |||
| Adipose tissue | Increased adipogenesis in vitro | Ge et al[60] | ||
| inhibit lipolysis in vitro and in vivo | Hong et al[59] and Ge et al[60] | |||
| Improved inflammation in ex vivo | Al-Lahham et al[66] | |||
| Intestine | Promoted gluconeogenesis in vivo | De Vadder et al[91] | ||
| Whole body | Increased energy expenditure and fat oxidation in vivo and in humans | den Besten et al[47], Canfora et al[77] and Chambers et al[79] | ||
| Butyrate | Skeletal muscle | Increased lipid oxidation in vitro and in vivo | Gao et al[48] | |
| Liver | Decreased lipogenesis in vivo | den Besten et al[47] | ||
| Increased lipid oxidation in vivo | den Besten et al[47], Gao et al[48] and Mollica et al[49] | |||
| Adipose tissue | decreased lipolysis in vitro | Ohira et al[67] | ||
| Improved inflammation in vitro | Ohira et al[67] | |||
| Increased thermogenesis in vivo | Gao et al[48] and Li et al[74] | |||
| Intestine | Promoted gluconeogenesis in vitro and in vivo | De Vadder et al[91] | ||
| Whole body | Increased energy expenditure and fat oxidation in vivo and in humans | den Besten et al[47], Gao et al[48] and Canfora et al[77] | ||
| Succinate | Intestine | Promoted gluconeogenesis in vivo | De Vadder et al[92] | |
| Protein | ||||
| Protein-derived | Hydrogen sulfide | Liver | Increased gluconeogenesis in vitro | Zhang et al[32] |
| Decreased glycogen synthesis in vitro | Zhang et al[32] | |||
| Indole | Adipose tissue | Increased inflammation in vivo | Virtue et al[10] | |
| Indole-3-carboxylic acid | Adipose tissue | Increased inflammation in vivo | Virtue et al[10] | |
| Phenylacetic acid | Liver | Increased lipogenesis in ex vivo and in vivo | Hoyles et al[46] | |
| Lipid and others | ||||
| Linoleic acid-derived | 10-oxo-12(Z)-octadecenoic acid | Adipose tissue | Induced adipogenesis in vitro | Goto et al[55] |
| Increased thermogenesis in vivo | Kim et al[81] | |||
| Conjugated linoleic acid | Adipose tissue | Increased energy expenditure | Takahashi et al[82], Park et al[83] and Lee et al[84] | |
| Ferulic acid-derived | Ferulic acid 4-O-sulfate and Dihydroferulic acid 4-O-sulfate | Skeletal muscle | Increased glucose uptake in vitro | Houghton et al[19] |
| Resveratrol-derived | Trans-resveratrol 4’-O-glucuro-nide and Trans-resveratrol 3-O-sulfate | Skeletal muscle | Increased glucose uptake in vitro | Houghton et al[19] |
| Berries-derived | Isovanillic acid 3-O-sulfate | Skeletal muscle | Increased glucose uptake in vitro | Houghton et al[19] |
| Catecin-derived | 4-hydroxy-5-(3,4,5-trihydroxyphenyl) valeric acid, 5-(3,4,5-trihydroxyphenyl)-γ-valerolac-tone, and 5-(3-hydroxyphenyl) valeric acid | Skeletal muscle | Increased glucose uptake in vitro | Takagaki et al[22] |
| Catecin-derived | 5-(3,5-dihydroxyphenyl)-γ-valerolactone | Skeletal muscle | Increased glucose uptake in vitro and in vivo | Takagaki et al[22] |
| Bacteria-derived | Extracellular vesicles | Skeletal muscle | Decreased glucose uptake in vivo | Choi et al[20] |
| Choline-derived | Trimethylamine N-oxide | Liver | Increased gluconeogenesis in ex vivo and in vivo | Chen et al[33] and Gao et al[43] |
| Adipose tissue | Promoted inflammation in vivo | Gao et al[43] | ||
- Citation: Jang HR, Lee HY. Mechanisms linking gut microbial metabolites to insulin resistance. World J Diabetes 2021; 12(6): 730-744
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/730.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.730
